(2-S)-2,7-DIHYDROXY-5-METHOXY-6,8-DIMETHYLFLAVANONE
Compound with spectra: 1 NMR, and 1 MS (GC)
| SpectraBase Compound ID | Tl6yvzOL6b |
|---|---|
| InChI | InChI=1S/C18H18O5/c1-10-15(20)11(2)17-14(16(10)22-3)13(19)9-18(21,23-17)12-7-5-4-6-8-12/h4-8,20-21H,9H2,1-3H3/t18-/m0/s1 |
| InChIKey | BIMVXOYXXZYVJF-SFHVURJKSA-N |
| Mol Weight | 314.34 g/mol |
| Molecular Formula | C18H18O5 |
| Exact Mass | 314.115424 g/mol |
| Enantiomer InChIKey | BIMVXOYXXZYVJF-GOSISDBHSA-N |
| Racemate InChIKey | BIMVXOYXXZYVJF-UHFFFAOYSA-N |
| Copyright | Copyright © 2020-2024 John Wiley & Sons, Inc. All Rights Reserved. |
|---|---|
| Source of Spectrum | WO2012023660A1 |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
- (2S)-2,7-dihydroxy-5-methoxy-6,8-dimethyl-2-phenyl-chroman-4-one
2,5-DIHYDROXY-7-METHOXY-8-METHYLFLAVANONE
2,5-DIHYDROXY-7-METHOXY-6-METHYLFLAVANONE
2,5-DIHYDROXY-6-METHYL-7-METHOXY-FLAVANONE
4H-1-Benzopyran-4-one, 2-(3,4-dimethoxyphenyl)-2,3-dihydro-2,5,7-trihydroxy-
4H-1-Benzopyran-4-one, 2,3-dihydro-2,5,7-trihydroxy-2-(2-methoxyphenyl)-
NDNYKKOQNGNFKS-LYJBJCQPSA-N
(S)-2,3-Dihydro-5-hydroxy-2-(2-hydroxyphenyl)-7-methoxy-6,8-dimethyl-4H-1-benzopyran-4-one
4',5,7-TRIHYDROXY-6-METHYL-8-(3-METHYL-[2-BUTENYL])-FLAVANONE
2-(4-hydroxyphenyl)-6,8-bis(3-methylbut-2-enyl)-5,7-bis(oxidanyl)-2,3-dihydrochromen-4-one
TEPHROCANDIDIN_A;2,3-DIHYDRO-7-HYDROXY-8-[(Z)-3-HYDROXY-3-METHYLBUT-1-ENYL]-5-METHOXY-2-PHENYLCHROMAN-4-ONE
| Title | Journal or Book | Year |
|---|---|---|
| C-Methylated Flavonoids from Cleistocalyx operculatus and Their Inhibitory Effects on Novel Influenza A (H1N1) Neuraminidase | Journal of Natural Products | 2010 |
This compound is available in the following databases:
KnowItAll NMR Spectral Library
Author: Wiley
The KnowItAll NMR Spectral Library offers a comprehensive collection of NMR reference spectra, including NMR, CNMR, and XNMR, and covers a wide range of compounds including organics, polymers, monomers, metabolites, and more. Learn more.